We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMBM
4001
DELISTED
Cambium Networks
CMBM
| $26.4K | ﹤0.01% |
14,430
-10,653
| -42% | -$20.2K |
|
4002
Metagenomi Therapeutics
MGX
$45.6M
| $25K | ﹤0.01% |
11,526
+1,324
| +13% | +$4.59K |
|
4003
Aemetis
AMTX
$119M
| $24.9K | ﹤0.01% |
10,814
-22,899
| -68% | -$64.2K |
|
4004
Retractable Technologies
RVP
$20.4M
| $24.8K | ﹤0.01% |
32,195
+22,094
| +219% | +$22.2K |
|
|
ATYR
4005
aTyr Pharma
ATYR
$46.4M
| $23.6K | ﹤0.01% |
+13,381
| New | +$24.3K |
|
|
OMGA
4006
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $22.2K | ﹤0.01% |
18,162
-204,233
| -92% | -$325K |
|
4007
Incannex Healthcare
IXHL
$35.3M
| $22.2K | ﹤0.01% |
+371
| New | +$22.9K |
|
4008
TMC The Metals Company
TMC
$1.59B
| $22.1K | ﹤0.01% |
+20,814
| New | +$23.3K |
|
|
WHWK
4009
Whitehawk Therapeutics
WHWK
$183M
| $21.7K | ﹤0.01% |
10,510
-10,120
| -49% | -$16.4K |
|
4010
Rallybio
RLYB
$86.6M
| $21.5K | ﹤0.01% |
2,296
-1,694
| -42% | -$16.3K |
|
4011
SmartRent
SMRT
$183M
| $21.3K | ﹤0.01% |
12,328
-14,435
| -54% | -$27.4K |
|
4012
CALL
SELLAS Life Sciences
SLS
$2.23B
| $21.1K | ﹤0.01% |
+16,900
| New | +$20.7K |
|
4013
PUT
Odyssey Marine Exploration
OMEX
$40.4M
| $20.8K | ﹤0.01% |
+25,100
| New | +$94.2K |
|
4014
Passage Bio
PASG
$15.9M
| $19.5K | ﹤0.01% |
+1,396
| New | +$22.2K |
|
4015
Atossa Therapeutics
ATOS
$22.8M
| $19.2K | ﹤0.01% |
842
-3,594
| -81% | -$72.6K |
|
|
OKUR
4016
OnKure Therapeutics
OKUR
$166M
| $18.8K | ﹤0.01% |
1,103
-846
| -43% | -$12.5K |
|
4017
InflaRx
IFRX
$256M
| $18.7K | ﹤0.01% |
12,207
-12,865
| -51% | -$19.6K |
|
|
CLSD
4018
DELISTED
Clearside Biomedical
CLSD
| $18.4K | ﹤0.01% |
967
-419
| -30% | -$7.15K |
|
|
WBX
4019
Wallbox
WBX
$95.3M
| $18.4K | ﹤0.01% |
+753
| New | +$20.6K |
|
4020
Fuel Tech
FTEK
$48M
| $17.9K | ﹤0.01% |
+17,071
| New | +$17.5K |
|
|
BYU
4021
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $17.5K | ﹤0.01% |
+17,355
| New | +$32.8K |
|
4022
Inuvo
INUV
$16M
| $17.1K | ﹤0.01% |
6,949
-6,636
| -49% | -$18.5K |
|
|
ASNS
4023
DELISTED
ACTELIS NETWORKS INC
ASNS
| $16.6K | ﹤0.01% |
+1,143
| New | +$17.8K |
|
4024
CALL
FuboTV Inc
FUBO
$245M
| $16K | ﹤0.01% |
942
-10,958
| -92% | -$198K |
|
|
WW
4025
DELISTED
WW International
WW
| $15.9K | ﹤0.01% |
18,168
-191,678
| -91% | -$186K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.